Amgen Inc. (AMGN) Q2 2015 Earnings Results

Amgen Beats on EPS, Stock Up 0.13%

Amgen's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock reacted modestly, rising by 0.13%, likely driven by the strong EPS performance and management's positive outlook on their product pipeline. However, the lack of revenue figures and guidance may leave investors cautious.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.57	N/A	+5.85%

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their future growth potential despite not providing specific guidance. They noted the importance of innovation in driving results.

Management highlighted the strength of their product pipeline.

They emphasized ongoing investments in research and development.

Amgen Beats on EPS, Stock Up 0.13%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Up 0.13%

Key numbers

Management commentary